Search details
1.
miR-17-92 cluster-BTG2 axis regulates B-cell receptor signaling in mantle cell lymphoma.
Cancer Sci
; 115(2): 452-464, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38050664
2.
Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations.
Blood
; 139(12): 1850-1862, 2022 03 24.
Article
in English
| MEDLINE | ID: mdl-34695176
3.
Triple targeting of RSK, AKT, and S6K as pivotal downstream effectors of PDPK1 by TAS0612 in B-cell lymphomas.
Cancer Sci
; 114(12): 4691-4705, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37840379
4.
Long-term follow-up after R-High CHOP/CHASER/LEED with Auto-PBSCT in untreated mantle cell lymphoma-Final analysis of JCOG0406.
Cancer Sci
; 114(8): 3461-3465, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37232264
5.
The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma.
Int J Mol Sci
; 23(6)2022 Mar 08.
Article
in English
| MEDLINE | ID: mdl-35328342
6.
Lenalidomide and pomalidomide potently interfere with induction of myeloid-derived suppressor cells in multiple myeloma.
Br J Haematol
; 191(5): 784-795, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32558939
7.
Sequential therapy of four cycles of bortezomib, melphalan, and prednisolone followed by continuous lenalidomide and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma.
Ann Hematol
; 99(1): 137-145, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31768675
8.
Carfilzomib monotherapy in Japanese patients with relapsed or refractory multiple myeloma: A phase 1/2 study.
Cancer Sci
; 110(9): 2924-2932, 2019 Sep.
Article
in English
| MEDLINE | ID: mdl-31336012
9.
Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2.
Invest New Drugs
; 37(2): 210-222, 2019 04.
Article
in English
| MEDLINE | ID: mdl-29931583
10.
Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma.
Ann Hematol
; 98(1): 131-142, 2019 Jan.
Article
in English
| MEDLINE | ID: mdl-29974231
11.
Weekly carfilzomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma: A phase 1 and PK/PD trial.
Cancer Sci
; 109(10): 3245-3252, 2018 Oct.
Article
in English
| MEDLINE | ID: mdl-30058108
12.
R-High-CHOP/CHASER/LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY.
Cancer Sci
; 109(9): 2830-2840, 2018 Sep.
Article
in English
| MEDLINE | ID: mdl-29957865
13.
Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma.
N Engl J Med
; 373(7): 621-31, 2015 Aug 13.
Article
in English
| MEDLINE | ID: mdl-26035255
14.
Correction to: Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma.
Ann Hematol
; 97(12): 2529-2530, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30054705
15.
An adult-onset case of chronic active Epstein-Barr virus infection with fulminant clinical course.
J Infect Chemother
; 24(6): 479-482, 2018 Jun.
Article
in English
| MEDLINE | ID: mdl-29426773
16.
Multicenter phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma.
Cancer Sci
; 108(5): 1007-1012, 2017 May.
Article
in English
| MEDLINE | ID: mdl-28267244
17.
Persistent detection of alternatively spliced BCR-ABL variant results in a failure to achieve deep molecular response.
Cancer Sci
; 108(11): 2204-2212, 2017 Nov.
Article
in English
| MEDLINE | ID: mdl-28801986
18.
Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myeloma.
Br J Haematol
; 178(4): 534-546, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28439875
19.
Clinicopathological analysis of 46 cases with CD4+ and/or CD56+ immature haematolymphoid malignancy: reappraisal of blastic plasmacytoid dendritic cell and related neoplasms.
Histopathology
; 71(6): 972-984, 2017 Dec.
Article
in English
| MEDLINE | ID: mdl-28795410
20.
Predicting risk factors for varicella zoster virus infection and postherpetic neuralgia after hematopoietic cell transplantation using ordered logistic regression analysis.
Ann Hematol
; 96(2): 311-315, 2017 Feb.
Article
in English
| MEDLINE | ID: mdl-27896415